Hantech Bio-Technology Co

Hantech Bio-Technology Co FCF/Debt

The Free Cash Flow to Debt Ratio of Hantech Bio-Technology Co (1294.TWO) as of Oct 28, 2026 is 207.67 %. In the previous year, Free Cash Flow to Debt Ratio was 135.89 % — a change of 52.83% (higher).

FCF/Debt

207.67 %

YoY

52.83%

Last updated:

Free Cash Flow to Debt Ratio of Hantech Bio-Technology Co is 2025 207.67 % . Free Cash Flow to Debt Ratio of Hantech Bio-Technology Co was 2024 135.89 % . It decreases by 52.83% higher compared to the previous year.

The Hantech Bio-Technology Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2019
165.36 TWD
Jan 1, 2020
7.94 TWD
Jan 1, 2021
-32.55 TWD
Jan 1, 2022
-24.19 TWD
Jan 1, 2023
-36.94 TWD
Jan 1, 2024
135.89 TWD
Jan 1, 2025
207.67 TWD
The Hantech Bio-Technology Co FCF/Debt history
YEARFCF/DebtYoY
207.67 %+52.83%
135.89 %-467.87%
-36.94 %+52.69%
-24.19 %-25.68%
-32.55 %-509.81%
7.94 %-95.20%
165.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hantech Bio-Technology Co Stock analysis

What does Hantech Bio-Technology Co do? Hantech Bio-Technology Co., Ltd. generates revenue by manufacturing and selling science-based health products, eco-friendly pouches, and dietary supplements. The company provides functional drinks, including health drinks and crystal jelly, and powder raw materials and capsules such as pearl powder and tortoise-deer concentrated powder. Products are sold to markets in China, Southeast Asia, and America, with packaging options ranging from square bags to wine bottle bags in capacities of 10-80ml (g). The firm focuses on functional drink production, offering health drinks and crystal jelly in various shaped pouches like round mouth bottles, Z-shaped bags, and stand-up bags. Powder raw materials and capsule products include pearl powder and tortoise-deer concentrated powder, targeting consumers seeking health and wellness solutions. Sales are distributed across China, Southeast Asia, and American regions. Hantech Bio-Technology Co., Ltd. serves customers in China, Southeast Asia, and America through its eco-friendly packaging solutions and science-based health products. The company’s product portfolio includes functional drinks, crystal jelly, and dietary supplements with diverse packaging formats. Sales are driven by the demand for health-focused products in these key markets. Hantech Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hantech Bio-Technology Co stock

Free Cash Flow to Debt Ratio of Hantech Bio-Technology Co is 207.67 % in 2025.

Free Cash Flow to Debt Ratio of Hantech Bio-Technology Co changed from 135.89 % to 207.67 %, representing a 52.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Hantech Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Hantech Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hantech Bio-Technology Co

All Key Metrics — Hantech Bio-Technology Co